Reunion Neuroscience Inc (REUN) Stock

DelistedNasdaq: REUNReunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America.

1.12
Final close · Jul 31, 2023

REUN is no longer traded. Reunion Neuroscience was delisted from the Nasdaq in July 2023.

Prices on this page are historical; the last trade was July 31, 2023 at $1.12.

Reunion Neuroscience stock price history

Split-adjusted closes, 2021–2023

REUN final trading statistics

Final close
$1.12
Final trading day
Jul 31, 2023
Market cap at delisting
$13.12M
Shares outstanding
11.72M
Final 52-week range
$0.63 – $7.62
Avg. volume (final 3 mo.)
432,521
All-time high (split-adj.)
$32.50 · Jul 2021
All-time low (split-adj.)
$0.64 · Apr 2023
Return since IPO
-90.1%
Beta
4.20
Book value / share
$1.82
Price / book
0.62
Final 52 wk
0.637.62

Reunion Neuroscience earnings per share

Earnings per share

Reunion Neuroscience revenue & net income

RevenueNet income

Reunion Neuroscience annual financials

Reunion Neuroscience Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2023$0.00-$66.2M-$3.23
FY2022$4.86M-$55.8M-$4.75
FY2021$960.9K-$23.4M-$6.74
FY2020$1.0K-$2.7M—

Last five fiscal years reported before the delisting; fiscal year ending March. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Reunion Neuroscience Inc

Reunion Neuroscience Inc., a clinical-stage biopharmaceutical company, develops therapeutic solutions for mental health conditions in North America. The company's lead asset includes RE104, a clinical-stage serotonergic psychedelic therapeutic product for antidepressant applications. It is also developing the RE200 series, which comprises molecules that are structurally designed to be similar to classical psychedelics with selective potency at the target serotonin 2A receptor (5HT2A) for potential chronic treatment in various patient populations and indications. The company was formerly known as Field Trip Health Ltd. Reunion Neuroscience Inc. was founded in 2008 and is headquartered in Toronto, Canada.

Reunion Neuroscience stock FAQ

What happened to Reunion Neuroscience stock?

Reunion Neuroscience stock was delisted from the Nasdaq. Its final close was $1.12 on July 31, 2023.

Is REUN stock still trading?

No. REUN was delisted from the Nasdaq in July 2023 and no longer trades on a U.S. exchange.

What was the last price of REUN stock?

REUN closed at $1.12 on its final trading day, July 31, 2023, for a market value of about $13.12M.

What were Reunion Neuroscience's revenue and earnings in its last full fiscal year?

Reunion Neuroscience reported revenue of $0.00 and net income of -$66.2M in fiscal 2023, its last full year as a public company.

When did Reunion Neuroscience go public?

Reunion Neuroscience Inc stock began trading on July 29, 2021.

Biotechnology stocks to research

All Healthcare stocks →